Establishment of humanized mice and its application progress in cancer immunotherapy

Tianlong Ding1,2, Yang Yu1, Xiaoyuan Pan3

  • 1The Second Clinical Medical College, Lanzhou University, Lanzhou, 730030, PR China.

Immunotherapy
|April 25, 2023
PubMed

Insights

Developing humanized mouse models is crucial for advancing cancer immunotherapy. These preclinical models aid in personalizing cancer treatments and improving patient outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Preclinical Research

Background:

  • Malignant tumors are highly prevalent, posing significant treatment challenges.
  • Current cancer immunotherapies show limited efficacy in many patients.
  • There is a critical need for effective preclinical models in cancer research.

Purpose of the Study:

  • To review the establishment of humanized mouse models.
  • To explore the application of these models in cancer immunotherapy.
  • To identify strategies for developing tailored cancer therapies.

Main Methods:

  • Discussion of humanized xenotransplantation mouse model creation.
  • Review of current literature on model applications in immunotherapy.
  • Analysis of model utility in treatment selection and prognosis assessment.

Main Results:

  • Humanized mouse models offer a platform for evaluating cancer treatments.
  • These models facilitate the assessment of immunotherapy efficacy.
  • They aid in predicting patient prognosis and treatment response.

Conclusions:

  • Humanized mouse models are essential for advancing cancer immunotherapy research.
  • These models hold promise for identifying personalized treatment strategies.
  • Further development and application of these models can improve patient care for advanced malignancies.